Paul Edwards

Paul has over 17 years of experience as a drug hunter working within the Pharmaceutical and Biotechnology industry and has led several Chemistry Departments composed of up to 74 staff members. Paul has gained experience working, most recently, in the anti-infective, bone and joint disease and cardiovascular therapeutic areas and he has successfully run programmes from idea to hit generation to candidate selection. Paul has extensive experience of the evaluation of in-licencing opportunities and he has led a number of external collaborations. To date, Paul has over 60 peer-reviewed publications and patents.

Currently, he is a member of the Advisory Board for Spinnovation Analytical NV who are based in Nijmegen, The Netherlands. He was recently Vice President of Chemistry for Boehringer Ingelheim(Canada) Ltd. based in Laval, Quebec. Before taking up this role at Boehringer Ingelheim he held a number of positions, most notably he was Director and Head of Chemistry for the biotechnology company Galapagos, based in Mechelen, Belgium. Prior to this he was Director of Medicinal Chemistry for Santhera Pharmaceuticals (previously Graffinity) based in Heidelberg, Germany. Before this he spent nearly seven year at Pfizer Global Research & Development based in Sandwich, Kent in the United Kingdom. Here he held various positions in the Medicinal Chemistry and Lead Discovery Technologies Departments. His first industrial employment came at Oxford Asymmetry International Ltd., (now Evotec), based in Abingdon, Oxfordshire in the United Kingdom. Prior to taking up tenure in industry, he was firstly a SmithKline Beecham postdoctoral fellow with Regents’ Professor Paul G. Gassman at the University of Minnesota, USA, and then a postdoctoral fellow with Professor Steven V. Ley, FRS at the University of Cambridge in the United Kingdom.

In 1989 Paul was awarded a BSc honours degree in Chemistry, followed in 1992 by a PhD degree in organic chemistry, both from the University of Leicester in the United Kingdom. In 2005 Paul received an MBA degree from the Open University in the United Kingdom.

Paul is a Fellow of the Chartered Management Institute (FCMI) and a Chartered Manager (CMgr), he is a Chartered Chemist and Fellow of the Royal Society of Chemistry (C.Chem, FRSC), and a Chartered Scientist (CSci).

Expertise
Antiviral, Chemistry-Medicinal, CVMD, Pain, Sexual Health, Small Molecule, UK